CoChat

Interactions between Retroviruses and the Host Cell Genome

Poletti, Valentina, Mavilio, Fulvio · 2018 · Molecular Therapy - Methods & Clinical Development
Cited by 76

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2017.10.001

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 71

  1. Schmidt, 2001, Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples, Hum. Gene Ther., 12, 743, 10.1089/104303401750148649 · DOI · Paper page
  2. Derse, 2007, Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses, J. Virol., 81, 6731, 10.1128/JVI.02752-06 · DOI · Paper page
  3. Taganov, 2004, Integrase-specific enhancement and suppression of retroviral DNA integration by compacted chromatin structure in vitro, J. Virol., 78, 5848, 10.1128/JVI.78.11.5848-5855.2004 · DOI · Paper page
  4. Berry, 2006, Selection of target sites for mobile DNA integration in the human genome, PLoS Comput. Biol., 2, e157, 10.1371/journal.pcbi.0020157 · DOI · Paper page
  5. Carteau, 1998, Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target, J. Virol., 72, 4005, 10.1128/JVI.72.5.4005-4014.1998 · DOI · Paper page
  6. Wu, 2005, Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses, J. Virol., 79, 5211, 10.1128/JVI.79.8.5211-5214.2005 · DOI · Paper page
  7. Hematti, 2004, Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells, PLoS Biol., 2, e423, 10.1371/journal.pbio.0020423 · DOI · Paper page
  8. Mitchell, 2004, Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences, PLoS Biol., 2, E234, 10.1371/journal.pbio.0020234 · DOI · Paper page
  9. Cattoglio, 2010, High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors, Blood, 116, 5507, 10.1182/blood-2010-05-283523 · DOI · Paper page
  10. Wang, 2009, Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells, Mol. Ther., 17, 844, 10.1038/mt.2009.16 · DOI · Paper page
  11. Cattoglio, 2010, High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion, PLoS ONE, 5, e15688, 10.1371/journal.pone.0015688 · DOI
  12. Marini, 2015, Nuclear architecture dictates HIV-1 integration site selection, Nature, 521, 227, 10.1038/nature14226 · DOI · Paper page
  13. Mulder, 2002, Interaction of HIV-1 integrase with DNA repair protein hRad18, J. Biol. Chem., 277, 27489, 10.1074/jbc.M203061200 · DOI · Paper page
  14. Kalpana, 1994, Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5, Science, 266, 2002, 10.1126/science.7801128 · DOI · Paper page
  15. Violot, 2003, The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1, J. Virol., 77, 12507, 10.1128/JVI.77.23.12507-12522.2003 · DOI · Paper page
  16. Li, 2000, Retroviral cDNA integration: stimulation by HMG I family proteins, J. Virol., 74, 10965, 10.1128/JVI.74.23.10965-10974.2000 · DOI · Paper page
  17. Emiliani, 2005, Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication, J. Biol. Chem., 280, 25517, 10.1074/jbc.M501378200 · DOI · Paper page
  18. Llano, 2004, Lens epithelium-derived growth factor/p75 prevents proteasomal degradation of HIV-1 integrase, J. Biol. Chem., 279, 55570, 10.1074/jbc.M408508200 · DOI · Paper page
  19. Maertens, 2006, Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin, J. Cell Sci., 119, 2563, 10.1242/jcs.02995 · DOI · Paper page
  20. Ge, 1998, Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation, EMBO J., 17, 6723, 10.1093/emboj/17.22.6723 · DOI · Paper page
  21. Bartholomeeusen, 2007, Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75, J. Mol. Biol., 372, 407, 10.1016/j.jmb.2007.06.090 · DOI
  22. Hughes, 2010, Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity, J. Biol. Chem., 285, 541, 10.1074/jbc.M109.036491 · DOI
  23. Bartholomeeusen, 2009, Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ, J. Biol. Chem., 284, 11467, 10.1074/jbc.M807781200 · DOI · Paper page
  24. Yokoyama, 2008, Menin critically links MLL proteins with LEDGF on cancer-associated target genes, Cancer Cell, 14, 36, 10.1016/j.ccr.2008.05.003 · DOI · Paper page
  25. Gijsbers, 2011, Role of the PWWP domain of lens epithelium-derived growth factor (LEDGF)/p75 cofactor in lentiviral integration targeting, J. Biol. Chem., 286, 41812, 10.1074/jbc.M111.255711 · DOI · Paper page
  26. van Nuland, 2013, Nucleosomal DNA binding drives the recognition of H3K36-methylated nucleosomes by the PSIP1-PWWP domain, Epigenetics Chromatin, 6, 12, 10.1186/1756-8935-6-12 · DOI · Paper page
  27. Schrijvers, 2012, LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs, PLoS Pathog., 8, e1002558, 10.1371/journal.ppat.1002558 · DOI · Paper page
  28. Fadel, 2014, TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism, J. Virol., 88, 9704, 10.1128/JVI.01397-14 · DOI · Paper page
  29. De Rijck, 2006, Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication, J. Virol., 80, 11498, 10.1128/JVI.00801-06 · DOI · Paper page
  30. Meehan, 2011, LEDGF dominant interference proteins demonstrate prenuclear exposure of HIV-1 integrase and synergize with LEDGF depletion to destroy viral infectivity, J. Virol., 85, 3570, 10.1128/JVI.01295-10 · DOI
  31. Ferris, 2010, Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration, Proc. Natl. Acad. Sci. USA, 107, 3135, 10.1073/pnas.0914142107 · DOI · Paper page
  32. Gijsbers, 2010, LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin, Mol. Ther., 18, 552, 10.1038/mt.2010.36 · DOI · Paper page
  33. De Rijck, 2010, High-resolution profiling of the LEDGF/p75 chromatin interaction in the ENCODE region, Nucleic Acids Res., 38, 6135, 10.1093/nar/gkq410 · DOI · Paper page
  34. Pandey, 2007, Transcriptional coactivator LEDGF/p75 modulates human immunodeficiency virus type 1 integrase-mediated concerted integration, J. Virol., 81, 3969, 10.1128/JVI.02322-06 · DOI · Paper page
  35. McKee, 2008, Dynamic modulation of HIV-1 integrase structure and function by cellular lens epithelium-derived growth factor (LEDGF) protein, J. Biol. Chem., 283, 31802, 10.1074/jbc.M805843200 · DOI · Paper page
  36. Vanegas, 2005, Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering, J. Cell Sci., 118, 1733, 10.1242/jcs.02299 · DOI · Paper page
  37. Vandegraaff, 2006, Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication, Virology, 346, 415, 10.1016/j.virol.2005.11.022 · DOI · Paper page
  38. Wang, 2012, HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor, Nucleic Acids Res., 40, 11518, 10.1093/nar/gks913 · DOI · Paper page
  39. Schrijvers, 2012, HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells, Retrovirology, 9, 84, 10.1186/1742-4690-9-84 · DOI · Paper page
  40. Cattoglio, 2007, Hot spots of retroviral integration in human CD34+ hematopoietic cells, Blood, 110, 1770, 10.1182/blood-2007-01-068759 · DOI · Paper page
  41. Ambrosi, 2011, Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors, PLoS Comput. Biol., 7, e1002292, 10.1371/journal.pcbi.1002292 · DOI
  42. Lelek, 2015, Chromatin organization at the nuclear pore favours HIV replication, Nat. Commun., 6, 6483, 10.1038/ncomms7483 · DOI · Paper page
  43. Di Nunzio, 2013, Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication, Virology, 440, 8, 10.1016/j.virol.2013.02.008 · DOI · Paper page
  44. Moloney, 1960, Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations, J. Natl. Cancer Inst., 24, 933
  45. Cavazza, 2013, Mechanisms of retroviral integration and mutagenesis, Hum. Gene Ther., 24, 119, 10.1089/hum.2012.203 · DOI · Paper page
  46. Felice, 2009, Transcription factor binding sites are genetic determinants of retroviral integration in the human genome, PLoS ONE, 4, e4571, 10.1371/journal.pone.0004571 · DOI · Paper page
  47. Biasco, 2011, Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell, EMBO Mol. Med., 3, 89, 10.1002/emmm.201000108 · DOI · Paper page
  48. Cavazza, 2016, Dynamic transcriptional and epigenetic regulation of human epidermal keratinocyte differentiation, Stem Cell Reports, 6, 618, 10.1016/j.stemcr.2016.03.003 · DOI
  49. Romano, 2016, Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment, Sci. Rep., 6, 24724, 10.1038/srep24724 · DOI
  50. Aiuti, 2007, Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy, J. Clin. Invest., 117, 2233, 10.1172/JCI31666 · DOI · Paper page
  51. Deichmann, 2011, Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy, Mol. Ther., 19, 2031, 10.1038/mt.2011.178 · DOI · Paper page
  52. Lin, 2003, The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes, J. Virol., 77, 5030, 10.1128/JVI.77.8.5030-5036.2003 · DOI · Paper page
  53. Lee, 1994, Protection of retroviral DNA from autointegration: involvement of a cellular factor, Proc. Natl. Acad. Sci. USA, 91, 9823, 10.1073/pnas.91.21.9823 · DOI · Paper page
  54. Studamire, 2008, Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors, Retrovirology, 5, 48, 10.1186/1742-4690-5-48 · DOI · Paper page
  55. Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017 · DOI · Paper page
  56. Belkina, 2012, BET domain co-regulators in obesity, inflammation and cancer, Nat. Rev. Cancer, 12, 465, 10.1038/nrc3256 · DOI · Paper page
  57. Umehara, 2010, Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain, J. Biol. Chem., 285, 7610, 10.1074/jbc.M109.062422 · DOI
  58. Hu, 2008, Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors, Mol. Ther., 16, 1617, 10.1038/mt.2008.135 · DOI · Paper page
  59. Moiani, 2014, Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells, Genes (Basel), 5, 415, 10.3390/genes5020415 · DOI
  60. Suerth, 2014, Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy, Viruses, 6, 4811, 10.3390/v6124811 · DOI
  61. Faschinger, 2008, Mouse mammary tumor virus integration site selection in human and mouse genomes, J. Virol., 82, 1360, 10.1128/JVI.02098-07 · DOI · Paper page
  62. Konstantoulas, 2014, Mouse mammary tumor virus-based vector transduces non-dividing cells, enters the nucleus via a TNPO3-independent pathway and integrates in a less biased fashion than other retroviruses, Retrovirology, 11, 34, 10.1186/1742-4690-11-34 · DOI · Paper page
  63. Gillet, 2011, The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones, Blood, 117, 3113, 10.1182/blood-2010-10-312926 · DOI · Paper page
  64. Heneine, 1998, Identification of a human population infected with simian foamy viruses, Nat. Med., 4, 403, 10.1038/nm0498-403 · DOI · Paper page
  65. Olszko, 2013, Foamy virus vectors for HIV gene therapy, Viruses, 5, 2585, 10.3390/v5102585 · DOI
  66. Trobridge, 2006, Foamy virus vector integration sites in normal human cells, Proc. Natl. Acad. Sci. USA, 103, 1498, 10.1073/pnas.0510046103 · DOI · Paper page
  67. Nowrouzi, 2006, Genome-wide mapping of foamy virus vector integrations into a human cell line, J. Gen. Virol., 87, 1339, 10.1099/vir.0.81554-0 · DOI · Paper page
  68. Nasimuzzaman, 2014, High-titer foamy virus vector transduction and integration sites of human CD34(+) cell-derived SCID-repopulating cells, Mol. Ther. Methods Clin. Dev., 1, 14020, 10.1038/mtm.2014.20 · DOI
  69. Olszko, 2015, Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection, Gene Ther., 22, 591, 10.1038/gt.2015.20 · DOI
  70. Hocum, 2016, Retargeted foamy virus vectors integrate less frequently near proto-oncogenes, Sci. Rep., 6, 36610, 10.1038/srep36610 · DOI
  71. Maruggi, 2009, Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design, Mol. Ther., 17, 851, 10.1038/mt.2009.51 · DOI · Paper page

Cited by

Metadata

Authors
Poletti, V., & Mavilio, F.
Venue
Molecular Therapy - Methods & Clinical Development
Publisher
Elsevier BV
Published
2018-03
Volume
8
Pages
31-41
ISSN
2329-0501
Cited by
76
References
43
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.